Follow us on Twitter
twitter icon@FreshPatents


Pension patents

      

This page is updated frequently with new Pension-related patent applications.




 Nanosuspension of natural materials and preparation method thereof patent thumbnailNanosuspension of natural materials and preparation method thereof
The present disclosure relates to a method for the preparation of a nanosuspension of at least one natural material, wherein the method comprises the steps of (a) providing at least one natural material having a particle size (d90) of less than 320 μm; (b) dispersing said at least one natural material of step (a) in a solvent; and (c) milling the dispersion of step (b) to a particle size (d90) of below 1000 nm. The nanosuspension is useful for the preparation of a medicament..
Apurano Pharmaceuticals Gmbh


 Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and  using same patent thumbnailPediatric oral suspension formulations of amoxicillin and clavulanate potassium and using same
The invention is directed to a pediatric oral suspension composition containing amoxicillin and clavulanate potassium where the clavulanate potassium is present in an amount equal to or less than about 21.5 mg/5 ml, and a method of treating bacterial infections by providing between about one to about fourteen dosage days of the composition.. .

 Concentrated suspension of agrochemicals in high electrolyte aqueous medium patent thumbnailConcentrated suspension of agrochemicals in high electrolyte aqueous medium
The present invention generally relates to stable suspension concentrates (sc) displaying shear thinning property and comprising: a water soluble salt, an electrolyte water thickening polymer (eg. Xanthan gum or guar gum), an insoluble solid agrochemical and water.
Akzo Nobel Chemicals International B.v.


 Pymetrozine suspension concentrates and its preparation method patent thumbnailPymetrozine suspension concentrates and its preparation method
The present disclosure relates generally to insecticide formulations. The present disclosure relates more particularly to aqueous pymetrozine formulations that can be provided in concentrate form and methods for making them.
Dow Global Technologies Llc


 Special modified expandable polystyrene copolymer particle for lost foam and production method therefor patent thumbnailSpecial modified expandable polystyrene copolymer particle for lost foam and production method therefor
The present invention discloses a special modified expandable polystyrene copolymer particle for a lost foam, which respectively comprises the following parts by weight: 90 to 100 parts of styrene; 3 to 8 parts of methyl methacrylate; 100 to 140 parts of deionized water; 0.2 to 0.5 part of benzoyl peroxide; 0.2 to 0.5 part of dicumyl peroxide: 0.1 to 0.5 part of tert-butyl peroxybenzoate: 0.001 to 0.01 part of anionic surfactant; 1 to 2 parts of suspension concentrate; 5.0 to 10.0 parts of foaming agent; 0.1 to 0.4 part of nucleator; 0.2 to 2 parts of organic bromine; 0.01 to 0.1 part of molecular weight regulator having the effect of increasing molecular weight, and 0.3 to 0.5 part of surface coating agent. The special modified expandable polystyrene copolymer particle for the lost foam and a production method therefor of the present invention effectively solve the existing problem of no special eps for lost foam casting, and have the advantages of reducing the generation of a carbon defect problem during foundry of a casting and increasing the molecular weight..
Zhejiang Castchem New Material Co.,ltd


 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative patent thumbnailCapsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
The present invention relates to a suspension formulation containing the active substance 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl -methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate, to a capsule pharmaceutical dosage form containing said suspension formulation, to a process for preparing said suspension formulation, to a process for preparing said capsule comprising said suspension formulation and to the packaging material for the finished capsule.. .
Boehringer Ingelheim International Gmbh


 Freeze dried drug nanosuspensions patent thumbnailFreeze dried drug nanosuspensions
The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage..
Janssen Pharmaceutical Nv


 Additive package compositions for pesticide suspension concentrate formulations patent thumbnailAdditive package compositions for pesticide suspension concentrate formulations
The present invention provides compositions containing a wetting agent, a polycarboxylate type surfactant, and a sulfonate type surfactant. The composition can be used as an additive package composition in a pesticide suspension concentrate formulation to enhance thermal stability..
Dow Global Technologies Llc


 Apparatus,  a dispensing system of a refrigerated appliance patent thumbnailApparatus, a dispensing system of a refrigerated appliance
An apparatus, method and system for sensing parameters related to water and/or ice being dispensed from a dispensing station of a refrigerated appliance is disclosed. The dispensing system includes a sensing system positionable at the dispensing station at the point of dispension for liquid and/or ice to sense a parameter related to dispensed water and/or ice and produce a sensing signal..
Whirlpool Corporation


 Aerosol formulations comprising formoterol fumarate dihydrate patent thumbnailAerosol formulations comprising formoterol fumarate dihydrate
The invention provides a method of producing a highly stable pharmaceutical aerosol suspension formulation suitable for use in a metered dose inhaler, the formulation comprising formoterol fumarate di-hydrate in suspension, a steroid in suspension, a propellant and ethanol, the method comprising the steps of drying the formoterol fumarate di-hydrate to a water content of 4.8 to 4.28%.. .
Jagotec Ag


Pumpable shelf-stable suspension of fibers in an organic phase

A pumpable shelf-stable suspension of fibers in an organic phase comprising 1.0-60 wt % of fibers and 0.01-10 wt % of a disubstituted urea is proposed as well as a method using the disubstituted urea to suspend fibers in an organic phase.. .
Basf Se

An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions

The present invention provides a process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising sterile active ingredient(s) such as sterile carbonic anhydrase inhibitors (cais) wherein the process does not involve the use of any special equipment's such as ball mill, milling bottle and/or jet mill the present process is simple, cost effective and efficient.. .
Sentiss Pharma Private Limited

Suspension compositions of physiologically active phenolic compounds & methods of making and using the same

The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid..
Humanetics Corporation

Concentrated natamycin suspension formulations

The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water.
Valent Biosciences Corporation

Adaptive mouth guard and use

A dental appliance is disclosed designed to protect a wearer's dentitions against injury from impacts suffered in sports or other activities that can cause chipping, fracturing, dislodging or evulsion of teeth. The appliance may be custom-fittable with at least one pocket having an energy absorbing fluid.
Akervall Technologies, Inc.

Fluid cartridge and dispension device

An arrangement for dispensing a fluid comprises a fluid cartridge comprising a casing for accommodating the fluid and a fluid dispensing unit configured for generating particles upon feeding the fluid in the casing with pressurized medium. The arrangement further comprises a dispenser device comprising a cartridge accommodation unit configured for accommodating the fluid cartridge and a pressure feed unit configured for feeding the fluid in a casing of the fluid cartridge with a pressurized medium upon accommodating the fluid cartridge in the cartridge accommodation unit to thereby generate the particles upon feeding the fluid in the casing with the pressurized medium..
Medic Activ Vertriebs Gmbh

Method of treating middle ear infections

Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.. .
Alcon Pharmaceuticals Ltd.

Cellulose suspension, the production and use thereof

The present invention relates to a phase-stable suspension of cellulose ii in water, having a high water retention capacity and a cellulose concentration between 0.1 and 5.0% by weight, a method of its preparation, and its use.. .
Lenzing Ag

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne.
Dow Pharmaceutical Sciences, Inc.

Ocular formulations for drug-delivery and protection of the anterior segment of the eye

Or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin k, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of compound-i or its free base, and suspension formulations comprising the particle compositions of compound-i or its free base..

Novel drug formulation

There is provided inter alia a pharmaceutical aqueous nanosuspension comprising (i) 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide in nanoparticulate form and a stabilizing agent.. .
Fab Pharma Sas

Synthesis, capping and dispersion of nanocrystals

Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield.
Pixelligent Technologies, Llc

Electric-drive all-terrain utility vehicle

The invention is an all-terrain utility vehicle comprising: a support chassis frame; four wheels removably attached to respective adjustable suspension components that are removably attached to the support chassis frame; a transfer case, an electric motor, and an engine mounted on the support chassis frame; removable personnel seats; and a battery mounted on the support chassis frame.. .

High-concentration monoclonal antibody formulations

The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. Via a pre-filled syringe.

Devices and methods for the controlled formation and dispension of small drops of highly viscous and/or non-newtonian liquids

The disclosed spray deposition systems and methods control the formation and dispensation of droplets during the atomization of a fluid. Such systems and methods generally can generate small quantities and droplets of a desired size of highly-viscous fluids and/or fluids having non-newtonian properties or other complex rheologies using mechanical systems and processes with the option of further controlling the droplet size and/or the volume of droplets with various enhancements.

Pharmaceutical composition comprising brinzolamide

The present invention provides an improved novel process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising an active ingredient(s) such as carbonic anhydrase inhibitors (cais) wherein the said process involves solubilization, followed by controlled precipitation of carbonic anhydrase inhibitors of the right particle size, e.g., less than 10 micron, preferably less than 5 micron (d90) by varying ph with a little or no homogenization. Said process further does not require the use of any special equipment such as ball mill, milling bottle and/or jet mill.

Nanoparticle isoflavone compositions & methods of making and using the same

The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein..

A dynamically adjustable suspension device

The present invention discloses a dynamically adjustable suspension device including one or more springs having similar or different spring rates, where said one or more springs are arranged in a pre-defined configuration, and a dynamically adjustable damper. The dynamically adjustable damper, includes a rotatable knob coupled to the dynamically adjustable damper to change the damping coefficient dynamically in real-time, means to rotate the knob so as to adjust damping coefficient in real-time while the dynamically adjustable suspension device being used, means to identify compression of the one or more springs by sensing one or more positions of the springs, between a fully elongated state and a fully compressed state in real-time..
Kpit Cummings Infosystems Limited

Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination

The invention relates to methods and compositions for treating demyelination and/or dysmyelination and/or promoting remyelination of neurons and/or preventing the development of myelin-related diseases by administering to a subject in need thereof an effective amount (either therapeutic or prophylactic) of an elemental gold crystal nanosuspension.. .
Gr Intellectual Reserve, Llc

Prosthetic socket suspension device embodiments

Embodiments of the technology include a prosthetic socket suspension device having a distal cup portion and a liner garment portion, these two portions being bonded together. In various embodiments, a distal cup may be disposed within a liner, a liner may be disposed within a distal cup, and a distal cup may be disposed between distally bifurcated internal and an external layers of a liner.
Lim Innovations, Inc.

Suspension concentrate composition comprising isothiazoline insecticide and activated charcoal

Subject matter of the present invention is a suspension concentrate composition comprising an a) isothiazoline insecticide and b) activated charcoal, wherein the composition is substantially free of a non-polar solvent. The invention further relates to a process for the preparation of said composition; a suspension obtainable by mixing water, an isothiazoline insecticide and activated charcoal; and to a method for controlling undesired attack by insects or mites, where the suspension concentrate composition or the suspension is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests..
Basf Se

Use of 2-amino-2-ethyl-1,3-propanediol as additive in aqueous suspensions of calcium carbonate-comprising materials while maintaining stable suspension conductivity

Use of 2-amino-2-ethyl-1,3-propanediol as an additive in an aqueous suspension, containing from 25 to 62 vol. % of at least one calcium carbonate-comprising material, wherein the use provides improved stability with regard to the conductivity of the suspension..
Omya International Ag

Stable suspension concentrate formulation for water-soluble compounds

The present invention is directed to an insecticidal water based suspension concentrate formulation comprising a water-soluble insecticide selected from the group consisting of n-cyanomethyl-4-(trifluoromethyl)nicotinamide and (ez)-1-(6-chloro-3-pyridylmethyl)-n-nitroimidazolidin-2-ylidineamine and at least one water-soluble salt selected from the group consisting of magnesium sulfate (hydrated and anhydrous forms) and sodium sulfate, wherein the water-soluble insecticide is present in an insecticidally effective amount and methods of use.. .
Fmc Corporation

Adjustable ride height, vehicle, system and kit

Disclosed herein is an adjustable suspension mount system that includes a first mount link pivotally attached to a mount feature and extending to a device used to support a load on a first wheel, the first mount link pivotally attached to the device. The mount feature is attached to or integrated into the frame of the vehicle.

Tissue dispenser for enabling tissue dispension for persons with restricted hand movement

The present invention provides a tissue dispensing system for dispensing a tissue with restricted hand movement, the system including a tissue holding element for storage of a tissue stack, an opening on a lower end of the tissue holding element through which one end of the tissue stack is disposed and an attachment element for attaching the tissue holding element to a garment, wherein the one end of the tissue stack is adapted to be pulled from with the restricted hand movement from the tissue holding element to release a portion of the tissue stack.. .

Crystalline anhydrate forms of a pharmaceutical

The invention provides and describes solid state 17α-ethynyl-androst-5-ene-3β,7β,17β-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol include form i anhydrate and form iv and form v solvates.
Harbor Therapeutics, Inc.

Ocular formulations for drug-delivery and protection of the anterior segment of the eye

Or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin k, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of compound-i or its free base, and suspension formulations compring the particle compositions of compound-i or its free base..

Micro-sensor body and manufacturing the same, as well as micro-sensor

The present disclosure relates to the field of sensor manufacturing technology, particularly discloses a method for manufacturing a micro-sensor body, comprising the steps of s1: applying a wet colloidal material on a substrate to form a colloidal layer, and covering a layer of one-dimensional nanowire film on the surface of the colloidal layer to form a sensor embryo; s2: drying the colloidal layer of the sensor embryo to an extent that the colloidal layer cracks into a plurality of colloidal islands, a portion of the one-dimensional nanowire film contracting into a contraction diaphragm adhered to the surface of the colloidal islands while the other portion of the one-dimensional nanowire film being stretched into a connection structure connected between the adjacent contraction diaphragms. By the method for manufacturing a micro-sensor body of the present disclosure, the contraction diaphragms and connection structures formed by stretching the one-dimensional nanowire film are connected stably, which enhances the stability of the sensor devices; and the cracking manner renders it easy to obtain a large-scale of sensor bodies with connection structure arrays in stable suspension..
Xiamen Hopergy Photovoltaic Technology Co., Ltd

Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

The present disclosure refers to a synergistic blend of konjac powder and xanthan gum that is included, as a natural suspending agent, in oral pharmaceutical suspensions. Oral pharmaceutical suspensions comprising the synergistic blend are aqueous solutions.
Professional Compounding Centers Of America (pcca)

Treatment methods using pharmaceutical solid state forms

The invention provides and describes solid state 17α-ethynyl-androst-5-ene-3β,7β,17β-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol include form i anhydrate and form iv and form v solvates.
Harbor Therapeutics, Inc.

Prosthetic suspension mounting assembly

A prosthetic suspension-mounting system which employs an improved flathead bolt and socket centering block combination for securement of an amputee-limb enveloping liner within a prosthesis. The liner has a strap fixedly attached on the bottom end of the liner by a flathead bolt.

Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative

The present invention relates to a suspension formulation containing the active substance 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate, to a capsule pharmaceutical dosage form containing said suspension formulation, to a process for preparing said suspension formulation, to a process for preparing said to capsule comprising said suspension formulation and to the packaging material for the finished capsule.. .
Boehringer Ingelheim International Gmbh

Highly concentrated drug particles, formulations, suspensions and uses thereof

Highly concentrated drug particle formulations are described, wherein the drug comprises between about 25 wt % and 80 wt % of the particle formulation. The particle formulations of the present invention comprise, for example, macromolecules, such as proteins and/or small molecules (such as steroid hormones).
Intarcia Therapeutics, Inc.

Suspension of inorganic material in phosphate ester, a flame retarded thermoplastic composition containing the same

There is provided herein a stable suspension of at least one of an inorganic oxide, an inorganic hydroxide, an inorganic carbonate and mixed salts thereof of the metals of groups ii and iii of the periodic table of elements in a liquid phosphate ester. There is also provided a flame retarded thermoplastic resin composition containing a hydrolysis-susceptible thermoplastic resin and the stable suspension.
Icl-ip America Inc.

Suspension compositions of cyclosporin a for subconjunctival and periocular injection

The present disclosure relates to suspension formulations and systems for the treatment of ocular conditions. The suspension formulations can include cyclosporin a and in some embodiments, form 1 or form 2 cyclosporin a.
Allergan, Inc.

Apparatus and methods for automated dispension of medications and supplements

A system for assembling and dispensing an order made up of one or more individually packaged items from a plurality of different individually packaged items includes a storage module containing one or more packages of each of the items, and a conveyor having selectively assignable spaces configured to receive the packaged items associated with a particular order and to transport the packaged items to a processing location. A pick device is movable relative to the storage module and is configured to retrieve a package from the storage module.
Remedi Technology Holdings, Llc





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Pension for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pension with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.7589

file did exist - 2792

0 - 1 - 51